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ABSTRACT
Objective To evaluate preferences and decision-making among high-risk pregnant women offered a choice between
Non-Invasive Prenatal Testing (NIPT), invasive testing or no further testing.
Methods Nationwide implementation study (TRIDENT) offering NIPT as contingent screening test for women at
increased risk for fetal aneuploidy based on ﬁrst-trimester combined testing (>1:200) or medical history. A
questionnaire was completed after counseling assessing knowledge, attitudes and participation following the
Multidimensional Measure of Informed Choice.
Results A total of 1091/1253 (87%) women completed the questionnaire. Of these, 1053 (96.5%) underwent NIPT, 37
(3.4%) invasive testing and 1 (0.1%) declined testing. 91.7% preferred NIPT because of test safety. Overall, 77.9% made
an informed choice, 89.8% had sufﬁcient knowledge and 90.5% had positive attitudes towards NIPT. Women with
intermediate (odds ratio (OR) = 3.51[1.70–7.22], p< 0.001) or high educational level (OR = 4.36[2.22–8.54], p< 0.001)
and women with adequate health literacy (OR = 2.60[1.36–4.95], p = 0.004) were more likely to make an informed
choice. Informed choice was associated with less decisional conﬂict and less anxiety (p< 0.001). Intention to
terminate the pregnancy for Down syndrome was higher among women undergoing invasive testing (86.5%)
compared to those undergoing NIPT (58.4%) (p< 0.001).
Conclusions The majority of women had sufﬁcient knowledge and made an informed choice. Continuous attention
for counseling is required, especially for low-educated and less health-literate women. © 2016 The Authors. Prenatal
Diagnosis published by John Wiley & Sons, Ltd.
Funding sources: Supported by a grant from the Netherlands Organisation for Health Research and Development (ZonMw, No. 200340002).
Conﬂicts of interest: Since 18 January 2016, Dr. Page-Christiaens has been employed as an Associated Medical Director at Illumina Inc. Dr. Oepkes previously
participated in clinical research sponsored by Ariosa Diagnostics and Natera Inc.
INTRODUCTION
Non-Invasive Prenatal Testing (NIPT) for fetal aneuploidy has
changed the landscape of prenatal screening worldwide.1 NIPT
uses sequencing of cell-free DNA (cfDNA) in maternal plasma
to screen for trisomy 21, 18 and 13 with a high accuracy in both
high- and low-risk populations.2,3 For women with an elevated
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risk based on ﬁrst-trimester or sequential screening, NIPT is
considered a good follow-up test that prevents the need for
invasive testing for most of them, thereby avoiding the risk of
iatrogenic loss of pregnancy.4 Invasive test conﬁrmation is,
however, still necessary because of potential false-positive
NIPT results.
Although the advantages offered byNIPT have created a strong
demand to implement this test, concerns have been raised
regarding the potential impact on informed decision-making.5
Both pregnant women and health professionals have expressed
fears that NIPT might become routinized or that women might
feel pressured to accept it.6–8 This could potentially undermine
the aim of prenatal screening, which is to enable pregnant
women to make an autonomous reproductive choice.9
Informed choice is most commonly deﬁned as a decision
made with sufﬁcient knowledge, consistent with the decision-
maker’s values and behaviorally implemented.10 The ability
to make an informed choice has been shown to be associated
with beneﬁcial psychological outcomes such as less decisional
conﬂict regarding the choice.11,12 To safeguard the process of
informed decision-making, the need for comprehensive
counseling on NIPT has been emphasized.9,13
On 1 April 2014, the Netherlands incorporated NIPT into
their governmentally supported and healthcare-funded Fetal
Trisomy Screening Program. This has been realized through a
nationwide implementation study: the TRIDENT study (Trial
by Dutch laboratories for Evaluation of Non-Invasive Prenatal
Testing). NIPT is being offered as an additional choice to
women with an elevated risk for fetal trisomy 21, 18 or 13 based
on ﬁrst-trimester combined testing (FCT) or based on medical
history. In the Netherlands, around 27% of pregnant women
decide to have FCT.14
The TRIDENT study had two main objectives. First, to
evaluate the clinical impact (uptake, test performance, turn-
around-time, pregnancy outcome), the results of which have
been reported separately (Oepkes et al.15 Paper Part I). In this
second part, we report on women’s preferences and decision-
making (informed choice), decisional conﬂict and anxiety.
METHODS
In the TRIDENT study, women at increased risk for fetal
trisomy were referred for in-depth counseling to one of the
eight Dutch Regional Prenatal Diagnosis Centers or their
satellite centers (n = 13). Pregnant women were offered the
choice between NIPT, invasive testing (chorionic villus
sampling (CVS) or amniocentesis (AC)) or no further testing.
Details on the TRIDENT study can be found in our separate
paper Part I (Oepkes et al.15). In seven of the eight centers,
women participating in the TRIDENT study during the ﬁrst ﬁve
months (1 April – 1 September 2014) were asked to ﬁll out two
questionnaires. Approval for the study was granted by the
Dutch government through a Population Screening Act
License (No. 350010-118701-PG) and local University Medical
Ethics Committees.
PARTICIPANTS
Pregnant women with an increased risk for fetal trisomy 21, 18
or 13 based on the results of the ﬁrst-trimester combined test
(cut-off risk ≥1:200) or based on medical history (i.e. a prior
pregnancy with a fetal trisomy 13, 18 or 21 or a parental
balanced Robertsonian translocation with increased risk on
T21 or T13) were considered eligible. Exclusion criteria were
gestational age <10 + 0weeks, <18 years old, inability to
provide informed consent, multiple pregnancies, vanishing
twin, nuchal translucency >3.5mm or other structural fetal
anomalies, maternal history of malignancy or a known
maternal chromosomal abnormality. All participants received
a unique TRIDENT study number.
INFORMATION AND COUNSELING
During the standard pre-test counseling, NIPT was discussed as
an alternative option for invasive testing in the case of an FCT
result indicating an elevated risk. All women were given oral
counseling by obstetricians, maternal fetal medicine specialists
or specially trained counselors. Women were also given written
information on both NIPT and invasive diagnostic testing (CVS
or AC). The following topics were addressed: test procedure
(including risk of invasive testing); reporting time; test
sensitivity for T21, 18 and 13; the meaning of an abnormal test
result and the necessity to conﬁrm abnormal NIPT results with
invasive testing. Furthermore, a dedicated website (in Dutch)
was launched (www.meerovernipt.nl) where women could ﬁnd
additional information or ask questions about NIPT and the
TRIDENT study.
PROCEDURE
The two questionnaires were designed by a multidisciplinary
team of social scientists, psychologists, obstetricians and a
clinical geneticist. Women were asked to ﬁll out the ﬁrst
questionnaire (Q1) directly after counseling. This was done
either on paper (six centers) or online (one center). Some
counselors in three centers, however, only asked women
choosing NIPT, and not those choosing invasive testing, to ﬁll
out the questionnaire. Because the overall number of women
electing invasive testing was low, this study mostly reﬂects
the ﬁndings of women choosing NIPT. The second
questionnaire (Q2) was completed after women had received
their test results. Only responses from the ﬁrst questionnaire
(Q1) are presented here.
MEASURES
Q1 registered the indication for follow-up testing (abnormal
FCT or medical history) and whether women would have had
FCT if NIPT had not been available. Next, women were asked
to indicate, from a list of options, the most important reason
for preferring either NIPT, invasive testing or no further testing.
Informed Choice was measured using a modiﬁed Multi-
dimensional Measure of Informed Choice (MMIC) developed
by Marteau et al.10,11 This method comprises the dimensions
of knowledge, attitude and uptake. The measure was adapted
to reﬂect the test options in the current study. Women’s
knowledge about NIPT was measured through a 5-item scale
designed for this study (Supplementary Table S1). The
questions covered information about NIPT’s characteristics
and implications of testing discussed in the information leaﬂet
and during counseling. Women’s knowledge of invasive testing
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was not assessed, except for one question that addressed the
accuracy of NIPT compared to invasive testing. Women’s
attitudes towards NIPT and invasive testing were each
measured using a semantic differential 5-point scale with four
bipolar adjective pairs based on van den Berg et al.12: negative–
positive, difﬁcult–easy, frightening–not-frightening and
reassuring–not-reassuring. In terms of reliability, the NIPT
attitude scale and invasive testing attitude scale were internally
consistent (Cronbach’s alpha = 0.79 and 0.85, respectively). The
type of test women decided to have was anonymously assessed
from the TRIDENT study laboratory database using the
TRIDENT study number.
The extent to which women accepted the fact that NIPT does
not give 100% certainty and the fact that invasive testing has a
miscarriage risk were both measured on a 5-point scale
(compressed to a 3-point scale (not acceptable; neutral;
acceptable) in analysis). Women’s attitude towards
termination of pregnancy in the case of Down syndrome or
trisomy 13 or 18 were both measured with a single item on a
5-point scale (compressed into a 3-point scale: probably not,
maybe/maybe not and probably).
Difﬁculties in decision-making or decisional conﬂict was
assessed by the Dutch version of the 16-item Decisional
Conﬂict Scale (DCS) developed by O’Connor16 and translated
and validated by Koedoot et al.17 Cronbach’s alpha for the
DCS was 0.97.
State anxiety was measured by a Dutch version of the six-
item short form of the state scale of the Spielberger State-Trait
Anxiety Inventory (STAI).18,19 Cronbach’s alpha was 0.87.
Health literacy was measured by a Dutch version of Chew’s
set of brief screening questions,20 translated and adapted by
Fransen et al.21 Cronbach’s alpha was 0.68.
The following sociodemographic variables were assessed:
age, parity, level of education, ethnicity, religion and level of
religiousness (active/somewhat active; not active/not
religious). Women were asked to indicate their gestational
age and whether they had conceived naturally or via assisted
reproductive technology (ART).
DATA ANALYSIS
Descriptive analyses were used to describe women’s
characteristics. For the MMIC analysis, knowledge sumscores
were dichotomized into sufﬁcient or insufﬁcient knowledge.
Because no standard criteria for ‘sufﬁcient’ or ‘insufﬁcient’
knowledge are available, we decided that a cut-off of >2/5
questions would constitute sufﬁcient knowledge.
Questionnaires of women who left more than two knowledge
questions blank were excluded from analyses. If a woman only
left one or two questions blank or checked the box ‘I don’t
know’ these were treated as incorrect answers. Attitude scores
where categorized into positive, neutral or negative. Because
people with a neutral attitude cannot be classiﬁed as either
having a positive or a negative attitude towards NIPT, they
were excluded from the analysis, as was proposed by van den
Berg et al.12 This is considered a better approach than the
original application (dichotomization) of the MMIC attitude
scale.22 Attitude was then combined with NIPT uptake to
assess value-consistency; women who chose NIPT and have a
positive attitude or women who declined NIPT and have a
negative attitude were classiﬁed as value-consistent. NIPT
acceptors with a negative attitude or NIPT decliners with a
positive attitude were classiﬁed as value-inconsistent. Based
on their knowledge and value-consistency, it was assessed
whether women had made an informed choice; if a woman
had sufﬁcient knowledge and was classiﬁed as value-
consistent, an informed choice had been made.10,11 If women’s
knowledge was insufﬁcient and/or they were classiﬁed as
value-inconsistent, their choice was considered to be
uninformed.
Differences between women who chose NIPT and women
who chose invasive testing were evaluated using the Fisher’s
Exact Test. To evaluate variables associated with making an
informed choice, univariate and multiple logistic regression
was used with statistical signiﬁcance set at p< 0.1 and
p< 0.05, respectively. A Mann–Whitney test was used (because
of non-normality of the items) to determine differences in
decisional conﬂict and anxiety between women making an
informed or uninformed choice. All analyses were performed
using SPSS version 20 for Windows (IBM Statistics for
Windows, IBM, NY, USA).
RESULTS
Women’s characteristics
In total, 1091/1253 pregnant women ﬁlled out Q1 (87%
response). Women’s characteristics are presented in Table 1;
61.5% of women were highly educated and 74.9% were of
Dutch origin. The mean age was 35.9 years (range 21–45) and
the mean gestational age was 14.0weeks (range 9–34). The
majority of women (86%) had been offered NIPT because of a
high risk (≥1:200) after FCT and 14% because of a medical
history.
For the informed choice analysis using the MMIC, 52
questionnaires had to be excluded because of missing data
on the attitude questions. Women with a neutral attitude
(n = 367) were excluded from analysis for the reasons
mentioned above. Seven women left more than two knowledge
questions blank, and these were excluded from analysis,
resulting in a total sample of 665 participants used in the
informed choice analysis.
Test preference
In our sample of 1091 women, 1053 (96.5%) had NIPT, 37
women (3.4%) had invasive testing and one woman (0.1%)
declined further testing. The main reason for preferring NIPT
was its safety (91.7%) (Table 2). Almost half of the women
who preferred invasive testing did so because of test
accuracy (47.1%) and 35.3% did so because of faster test
results. The only woman who refrained from testing did so
to avoid anxiety.
Women who had invasive testing signiﬁcantly more often
had a very high a priori risk (≥1:10), compared to women who
had NIPT (p< 0.001). There was no signiﬁcant difference in
age, level of education, parity, having a medical history and
conception via ART between women who chose invasive
testing and women who chose NIPT.
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The majority of women (77%) undergoing NIPT found it
acceptable that NIPT does not give 100% certainty, while
only 27% of the women undergoing invasive testing found
this acceptable (p< 0.001). In contrast, the fact that invasive
testing was associated with an increased risk of miscarriage
was acceptable to 73% of women undergoing invasive
testing and to only 15.9% of women having NIPT
(p< 0.001) (Table S2).
Intentions in the case of an abnormal result
Intention to terminate the pregnancy for Down syndrome was
higher among women who had invasive testing (86.5%)
compared to those who had NIPT (58.4%) (p< 0.001). This was
also the case for trisomy 13 and 18, although less pronounced
(94.6% vs 77.6%, respectively, p= 0.013) (Table S2).
Informed choice
As shown in Table 3, 89.8% of all women had sufﬁcient
knowledge on NIPT, 90.5% had a positive attitude towards
NIPT and 86.3% made a decision that was value-consistent.
Women with intermediate or higher education were more
likely to have sufﬁcient knowledge about NIPT than those
with a lower level of education (p< 0.001). There was no
signiﬁcant difference in knowledge between women who
had NIPT and women who had invasive testing. Answers to
separate knowledge questions are presented in
Supplementary Table S2.
Informed choice analysis showed that 77.9% of all women
had made an informed choice for NIPT. Those who made an
uninformed choice (22.1%) did so because of insufﬁcient
knowledge (8.4%), value-inconsistency (11.7%) or because they
had both insufﬁcient knowledge and a value-inconsistent
decision (2%) (Table 4). All women who had invasive testing
had a positive attitude towards NIPT and therefore, based on
the criteria of the MMIC, were scored as having made a
value-inconsistent choice. However, data showed that 78.6%
of these women also had a positive attitude towards invasive
testing, so their choice for invasive testing was value-consistent
and thus probably not uninformed (this could not be
calculated because women’s knowledge about invasive testing
was not measured). When women who had invasive testing
were excluded from the analysis, the percentage of informed
choice was 81%. There was no signiﬁcant difference in
informed choice between women who were offered testing
because of high-risk FCT results and those who had a high risk
based on their medical history. There was also no difference in
rates of informed choice between the seven participating
centers.
As shown in Table 5, univariate analysis revealed that
women making an informed choice were signiﬁcantly more
likely to be ≥36 years old, have intermediate or higher
education, have a low level of religiousness, have adequate
health literacy and had heard of NIPT before participating in
the study. Women of non-Western ethnicity were signiﬁcantly
less likely to make an informed choice. Multivariate analysis
showed that women with an intermediate- (odds ratio (OR)
= 3.51 [95%conﬁdence interval (CI), 1.70–7.22], p< 0.001) and
high level of education (OR= 4.36 [95%CI, 2.22–8.54],
p< 0.001) and those having adequate health literacy
(OR = 2.60 [95%CI, 1.36–4.95], p = 0.004) were signiﬁcantly more
likely to make an informed decision.
Table 1 Characteristics of participants (n=1091)
Characteristics n (%)
Maternal age (y) (missing 7)
≤25
26–35
≥36
24 (2.2)
424 (39.1)
636 (58.7)
Level of educationa (missing 2)
Low
Intermediate
High
92 (8.4)
327 (30.0)
670 (61.5)
Ethnicityb (missing14)
Dutch
Other Western
Non-Western
807 (74.9)
129 (12.0)
141 (13.1)
Religionc (missing 5)
None
Christian
Muslim
Hindu
Other
679 (62.5)
321 (29.6)
42 (3.9)
14 (1.3)
30 (2.8)
Level of religiousness (missing 10)
(Somewhat) Active
Not active/not religious
205 (19.0)
876 (81.0)
Health literacyd (missing 3)
Inadequate
Adequate
93 (8.5)
995 (91.5)
Parity (missing 12)
0
1 or more
407 (37.7)
672 (62.3)
Method of conception (missing 33)
Natural
Via assisted reproductive technologye
903 (82.8)
155 (14.2)
Gestational age (weeks) (missing 14)
9–24
≥25
1067 (99.1)
10 (0.9)
Indication for follow-up testing (missing 4)
FCT risk ≥1:200
Medical historyf
935 (86.0)
152 (14.0)
FCT risk for fetal trisomy (n.a. 152)
≥1:10
1:11–1:200
Unknown
50 (5.3)
785 (83.7)
104 (11.0)
FCT, ﬁrst-trimester combined test; n.a., not applicable.
Numbers may not add up to the total because of missing values.
aLow: elementary school, lower level of secondary school, lower vocational training;
Medium: higher level of secondary school, intermediate vocational training, High:
high vocational training, university.23
bEthnicity was categorized as Dutch, Other Western or Non-Western by the following
algorithm: Dutch if both parents were born in the Netherlands; Other Western if at
least one of their parents was born in Europe (excluding Turkey), North America,
Oceania, Indonesia or Japan; and Non-Western if at least one of their parents was
born in Africa, Latin America, Asia (excluding Indonesia and Japan) or Turkey. If both
parents were born abroad, then by country of the mother.23
cChristian: Calvinism, Protestantism, Roman Catholic, Reformed and Baptism.
Other: for example, Jewish, Buddhist and Jehovah’s witness.
dInadequate health literacy if answered other than ‘never’ or ‘occasionally’ on one or
more items, based on Chew et al.20
eIntrauterine insemination (IUI) (n = 47); in vitro fertilization (IVF) (n = 38); intra-
cytoplasmic sperm injection (ICSI) (n = 26); preimplantation genetic diagnosis (PGD)
(n = 14); ovulation induction (n = 12); other (n = 18).
fPrevious child with a trisomy 21, 18 or 13 (n = 114), or other disorder (n = 17);
ultrasound anomaly (n = 9); pregnant by intra-cytoplasmic sperm injection (ISCI)
(n = 7); parental Robertsonian translocation (n = 5).
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Decisional conﬂict and anxiety
Women who made an uninformed choice experienced more
decisional conﬂict (Median (Mdn) = 21.88) than women who
made an informed choice (Mdn= 6.25), U = 26 942, p< 0.001,
r =0.22. Moreover, women who made an uninformed choice
(Mdn= 50.00) experienced more anxiety than those who made
an informed choice (Mdn = 36.67), U = 18 737, p< 0.001,
r =0.34.
DISCUSSION
The majority of high-risk pregnant women preferred NIPT
because it is safe for the child. Higher test accuracy and
faster results were the most frequently mentioned reasons
to prefer invasive testing. Most women had sufﬁcient
knowledge, a positive attitude towards NIPT and were able
to make an informed choice. Women with an intermediate
or high level of education and adequate health literacy were
more likely to make an informed choice. Informed choice
was associated with experiencing less decisional conﬂict
and less anxiety.
Women choosing NIPT, as compared to those undergoing
invasive testing, were less likely to accept the miscarriage risk
of invasive testing and less often considered pregnancy
termination for Down syndrome. This might imply that
women opting for NIPT have different motives than women
opting for invasive testing in that they want to prepare
themselves for a child with Down syndrome and therefore
prefer a risk-free test. Results from two questionnaire studies
also showed that NIPT will probably be used more readily in
women who just want to prepare themselves.24,25 In a UK
study, where women were offered NIPT as a second screening
test through the National Health Service (NHS), 31% (13/42) of
women with a conﬁrmed diagnosis of Down syndrome after
NIPT continued the pregnancy, compared to 7% (2/29) after
direct invasive testing.26 It needs to be established if this
remains true once NIPT is fully incorporated in prenatal care.
Women who had invasive testing signiﬁcantly more often had
a very high a priori risk (≥1:10). In that case, it is
understandable that they would prefer a test that is more
accurate and delivers faster results, as was also concluded from
a previous study in the US.27
Table 2 Reasons for preferring NIPT, invasive testing or no further testing
Test choice Reason n (%)
NIPT (n = 1053) (missing 55) It’s safe for my baby
My doctor advised me to have NIPT
It can be done early in pregnancy
It’s easy to do
My partner wanted it
Other reasons
915 (91.7)
28 (2.8)
21 (2.1)
17 (1.7)
2 (0.2)
15 (1.5)
Invasive testing (n = 37) (missing 3) Test accuracy
Faster test results
It gives me more information about the unborn child
My doctor advised me to have invasive testing
Other reasons
16 (47.1)
12 (35.3)
3 (8.8)
1 (2.9)
2 (5.9)
No testing (n = 1) (Follow-up) testing gives me anxiety 1 (100)
Table 3 Description and characteristics of the informed choice measures
Measure Description Items Reliability Range
Mean
(SD) Cut-off Outcome
Knowledge
score
Knowledge about characteristics of NIPT and
meaning of test results
Five correct/
incorrect items
— 0–5 4.0
(1.1)
>2 Sufﬁcient
knowledge: 89.8%
Attitude
scale
Attitude towards having NIPT Four 5-point items 0.79 4–20 16.7
(3.5)
>14 = positivea
<10 = negativea
Positive attitude:
90.5%
Negative attitude:
9.5%
Test uptake Whether the woman had NIPT or not Based on
laboratory records
— — — — Test uptake: 96.5%
Value-
consistency
Consistency between value (attitude) and
behavior (test uptake)
Calculatedb — — — — Value-consistent:
86.3%
Informed
choice
A knowledgeable and value-consistent
decision
Calculatedc — — — — Informed
choice: 77.9%
SD, standard deviation.
aAttitudes were divided into three equal categories. Neutral attitudes (the middle category) (n = 367) were excluded from the analysis.12
bWomenwho had a positive attitude towards NIPT and chose to haveNIPT or womenwho had a negative attitude and chose not to have NIPT were classiﬁed as value-consistent.
cAn informed choice was made if a woman had sufﬁcient knowledge and made a value-consistent decision. In all other cases, the decision was labeled as uninformed.
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In our study, the rate of informed choice among women who
chose NIPT (81%) is somewhat lower to that shown in the
recent UK NHS study (94% informed choice).22 In our study,
we also showed that most women choosing invasive testing
made a value-consistent decision.
In line with previous studies,11,12 the results of the present
study underscore the importance of making an informed
choice in connection with beneﬁcial psychological outcomes
such as experiencing less decisional conﬂict. In contrast to
other studies,12,28 we also found that the anxiety level was less
high in women making an informed choice as compared to
those making an uninformed choice.
The high rate of informed choice in our patient cohort most
likely results from the intensive information and counseling
that women received from counselors who were specially
trained for the study. It is conceivable that the rate of informed
choice decreases once NIPT is offered outside the study
context. To safeguard informed decision-making, emphasis
has to be placed on further development of information tools
and maintaining good counseling. The use of decision aids29,30
or visuals aids such as an informational ﬁlm31 may have a
positive effect on informed decision-making by improving
knowledge and assisting women in making decisions that are
consistent with their values. Special attention should be given
to women with a lower educational level and/or inadequate
health literacy. A study among Latina women in the US showed
that women with a lower level of education more often decline
NIPT based on insufﬁcient knowledge.32 Moreover, women
from ethnic minority groups less often make an informed
choice about prenatal testing.33 Diversifying the ways through
which information is communicated might support informed
decision-making,32 for example, by providing written
information in different languages33 or using visual aids.
Because NIPT was offered as a contingent screening test,
women (excluding those with an indication based on medical
history) already had made the decision to have prenatal
screening with FCT. This means that they had already reﬂected
on prenatal testing before having to decide whether to have
NIPT or not. To enable women to make an informed choice,
counselors should discuss the advantages and disadvantages
of both NIPT and invasive testing. When used as a ﬁrst-tier
screening test, the choice to accept or decline NIPT will become
the ﬁrst decision-making moment about prenatal screening,
requiring additional training of counselors, and new patient
material to be developed and tested for this situation.
The strength of this study is its large sample size. Participants
were recruited nationwide, resulting in the inclusion of women
from both urban and less urban areas. A weakness of the study
is a possible underrepresentation of women who chose invasive
testing instead of NIPT in some of the participating centers.
Table 4 Types of informed and uninformed choice (n=665)a
Knowledge Attitude Uptake n %
Informed choice Good
Good
Positive
Negative
Yes
No
518
0
77.9
0
Uninformed
choice
Good
Good
Poor
Poor
Poor
Poor
Positive
Negative
Positive
Negative
Positive
Negative
No
Yes
Yes
No
No
Yes
22
56
56
0
6
7
3.3
8.4
8.4
0
0.9
1.1
aTypology based on Marteau et al.10 Women with ‘neutral attitudes’ (n = 367) were
excluded from the analysis, based on van den Berg et al.12
Table 5 Univariate and multiple logistic regression: factors associated with making an informed choice
Variable
Univariate logistic regression
Informed choice (n = 665)
Multiple logistic regression
Informed choice (n = 581)a
Odds ratio (95%CI) p-Valueb Odds ratio (95%CI) p-Valuec
Age
≤25
26–35
≥36
2.85
4.29
(0.80–10.16)
(1.21–15.21)
0.014
0.106
0.024
1.50
2.25
(0.35–6.41)
(0.53–9.58)
0.113
0.592
0.275
Level of education
Low
Intermediate
High
4.10
4.56
(2.11–7.98)
(2.46–8.44)
<0.001
<0.001
<0.001
3.51
4.36
(1.70–7.22)
(2.22–8.54)
<0.001
<0.001
<0.001
Ethnicity
Dutch
Other Western
Non-Western
0.75
0.42
(0.45–1.26)
(0.25–0.71)
0.005
0.279
0.001
0.77
0.58
(0.43–1.38)
(0.32–1.06)
0.181
0.385
0.074
Low level of religiousness
Adequate health literacy
1.60
3.14
(1.02–2.52)
(1.77–5.57)
0.041
<0.001
1.23
2.60
(0.73–2.04)
(1.36–4.95)
0.438
0.004
Parity ≥1
Already heard of NIPT
0.96
2.28
(0.66–1.40)
(1.26–4.10)
0.838
0.006
—
1.90
—
(0.98–3.67)
—
0.056
CI, conﬁdence interval.
aMultiple logistic regression excluded 84 women who had missing values on one of the variables.
bStatistical signiﬁcance set at p< 0.1.
cStatistical signiﬁcance set at p< 0.05.
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Because no information was available on the survey decliners,
potential selection bias cannot be excluded. Moreover, although
the MMIC is often used as a measure of informed choice for
screening, it does have some limitations. It requires a knowledge
measure that is speciﬁc to the condition being tested, but
because there is no gold standard for good knowledge this is
subjective.34 In our study, only knowledge on NIPT was
assessed. To fully comprehend whether women made an
informed choice, also knowledge of invasive testing should have
been assessed. Another limitation of using the MMIC is that,
because it is developed to measure informed choice between
women either accepting or declining a test, it is unable to
account for variations that exist when measuring informed
choice between women choosing between different tests, as
seen in our study with women who had both a positive attitude
towards NIPT and invasive testing. Recently, the MMIC has
been adapted and validated for women considering NIPT as a
second screening test, also including women’s deliberation.22
Our sample predominantly comprised older, highly educated
women. However, Dutch women are shown to be more likely
to have prenatal screening if they are older and have above-
average income.35 Moreover, highly educated women often
delay childbearing and are thus more likely to have a high risk
result on the FCT. Finally, in the Netherlands, prenatal testing
is offered in a nationally organized prenatal screening system,
the uptake of which is relatively low (~27%),14 and thus caution
is needed when generalizing the results to other contexts, for
example, to other countries.
In conclusion, implementation of NIPT within the setting of
the TRIDENT study was successful as the knowledge of the vast
majority of pregnant women on NIPT was sufﬁcient and most
were able to make an informed decision. Most women choose
NIPT because they want a safe test. Compared to women having
invasive testing, womenwho choose NIPT less frequently intend
to terminate their pregnancy in the case of Down syndrome,
Edwards syndrome or Patau syndrome, possibly indicating that
they more often undergo NIPT just to prepare themselves. To
safeguard informed decision-making on NIPT outside the
context of a controlled study, emphasis has to be placed on
maintaining information and counseling skills among obstetric
caregivers and exploring innovative strategies and counseling
aids especially, but not exclusively, for women with low
educational levels and/or inadequate health literacy.
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WHAT’S ALREADY KNOWN ABOUT THIS TOPIC?
• NIPT is offered as alternative to invasive testing to screen pregnant
women at high risk for fetal aneuploidy.
• Although NIPT has many advantages, concerns have been raised
about the consequences for informed decision-making.
WHAT DOES THIS STUDY ADD?
• Implementation of NIPT in a national healthcare-funded prenatal
screening program, accompanied by pre-test counseling, results in
most women having sufﬁcient knowledge and making an informed
choice
• Compared to women choosing invasive testing, women
undergoing NIPT have less intention to terminate the pregnancy
for Down syndrome.
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